Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
About this item
Full title
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
The New England journal of medicine, 2023-07, Vol.389 (4), p.297-308
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In a phase 3a trial involving adults with type 2 diabetes who had not previously received insulin, glycemic control was better with once-weekly insulin icodec than with once-daily insulin glargine U100.
Alternative Titles
Full title
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2829704947
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2829704947
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2303208
